Long-Term Immunogenicity of the Norovirus GI.1/GII.4 Bivalent Virus-like Particle (VLP) Vaccine (NoV Vaccine) in Adults
Public ClinicalTrials.gov record NCT03039790. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Long-Term Immunogenicity Follow-up Trial of Adult and Elderly Subjects Who Have Previously Received an Intramuscular Injection of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine
Study identification
- NCT ID
- NCT03039790
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Takeda
- Industry
- Enrollment
- 528 participants
Conditions and interventions
Conditions
Interventions
- NoV Vaccine Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 20, 2017
- Primary completion
- Jul 21, 2021
- Completion
- Jul 21, 2021
- Last update posted
- Nov 8, 2022
2017 – 2021
United States locations
- U.S. sites
- 9
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Simon-Williamson Clinic/Synexus Clinical Research US, Inc | Birmingham | Alabama | 35211 | — |
| Synexus Clinical Research US, Inc./Fountain Hills Family Practice, P.C. | Fountain Hills | Arizona | 85268 | — |
| Synexus Clinical Research US, Inc/Southwest Family Medicine | Littleton | Colorado | 80127 | — |
| Miami Research Associates | Miami | Florida | 33143 | — |
| Johnson County Clin-Trials | Lenexa | Kansas | 66219 | — |
| St. Louis University, School of Medicine | St Louis | Missouri | 63106 | — |
| Regional Clinical Research Inc. | Endwell | New York | 13760 | — |
| University of Rochester | Rochester | New York | 14642 | — |
| Benchmark Research Austin | Austin | Texas | 78705 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03039790, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 8, 2022 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03039790 live on ClinicalTrials.gov.